Retroviruses, genes and schizophrenia

Clinical Neuroscience Research

Volumn 1, Issue 1-2, 2001, Pages 164-169

  Yolken, Robert H ^a   Karlsson, Håkan ^b   Bayer, Thomas A ^c   Johnston Wilson, Nancy ^a   Yee, Frances ^a   Torrey, E Fuller ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d Stanley Foundation   (United States)

Author keywords

Endogenous retroviruses; Gene environmental interactions; Genes; Retroviruses; Schizophrenia

Indexed keywords

EID: 0043107795     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1566-2772(00)00018-9     Document Type: Article

References (53)

1. Murray GJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 1997;349(9063):1436-1442.
2. Rees MI, Fenton I, Williams NM. Autosome search for schizophrenia susceptibility genes in multiply affected families. Mol Psychiatry 1999;4(4):353-395.
3. Faraone SV, Matise T, Svrakie D. Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet 1998;81(4):290-295.
4. Levison DF, Mahtani MM, Nancarrow DJ. Genome scan of schizophrenia. Am J Psychiatry 1998;155(6):741-750.
5. Havatta I, Lichtermann D, Juvonen H. Linkage analysis of putative schizophrenia gene candidate regions on chromosomes 3p 5q, 6p, 8p, 20p and 22q in a population-based sampled Finnish family set. Mol Psychiatry 1998;3(5):452-457.
6. O'Donovan MC, Owens MJ. Candidate-gene association studies of schizophrenia. Am J Hum Genet 1999;65(3):587-592.
7. Tallerico T, Ulpian C, Liu IS. Dopamine D2 receptor promoter polymorphism: no association with schizophrenia. Lancet 1997; 349(9063):1436-1442.
8. Karayiorgon M, Kasch L, Lasseter VK. Report from the Maryland Epidemiology Schizophrenia Linkage Study: no evidence for linkage between schizophrenia and a number of candidate and other genomic regions using a complex dominant model. Am J Med Genet 1994;54(4):345-353.
9. Chen AC, Kalsi G, Brynjolfsson J. Exclusion of linkage between schizophrenia and the gene encoding a neutral amino acid glutamate/ aspartate transporter SLC1A5. Am J Med Genet 1997;74(1):50-52.
10. Hawi Z, Straub RE, O'Neill A, Kendler KS, Walsh D, Gill M. No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families. Psychiatry Res. 1998;81(2):111-116.
11. Shinkai T, Ohmori O, Kojima H, Tirao T, Suziki T, Abe K. Association study of the 5-HT6 receptor gene in schizophrenia. Am J Med Genet 1999;88(2):120-122.
12. Kawinishi Y, Harada S, Tachikawa H, Okubo T, Shiraishi H. Novel mutations in the promoter and coding region of the human 5-HT1A receptor gene and association analysis in schizophrenia. Am J Med Genet 1998;81(5):434-439.
13. Asherson P, Mant R, Williams N. A study of chromosomes 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder. Mol Psychiatry 1998;3(4):310-320.
14. Sasaki T, Hattori M, Sakai T. The monoamine oxidase-A gene and major psychosis in Japanese subjects. Biol Psychiatry 1998; 44(9):922-924.
15. He L, Li T, Melville C. 102T/C polymorphism of serotonin receptor type 2A gene is not associated with schizophrenia in either Chinese or British populations. Am J Med Genet 1999;88(1):95-98.
16. Marshall SE, Bird TG, Hart K, Welsh KI. Unified approach to the analysis of genetic variation in serotonergic pathways. Am J Med Genet 1999;88(6):621-627.
17. Lin CH, Tsai SJ, Yu YW. No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenia or clozapine response in a Chinese population. NeuroReport 1999;10(1):57-60.
18. Chen CH, Lee YR, Chung MY. Systematic mutation analysis of the catechol O-methyltranferase gene as a candidate gene for schizophrenia. Am J Psychiatry 1999;156(8):1273-1275.
19. Breen G, Fox H, Glen I, Collier D, Shaw D, St. Claire D. Association study of the CACNIA4 (SCA6) triplet repeat and schizophrenia. Psychiatr Genet 1999;9(2):111-113.
20. Meissner B, Purmann S, Schurmann M. hSKCa3: a candidate gene for schizophrenia? Psychiatr Genet 1999;9(2):91-96.
21. Martorell L, Pupana MA, Valero J. Anticipation is not associated with CAG repeat expansion in parent-offspring pairs of patients affected with schizophrenia. Am J Med Genet 1999;88(1):50-56.
22. Torrey EF. Are we overestimating the genetic contribution to schizophrenia. Schizophr Bull 1992;18:159-170.
23. Torrey EF, Miller J, Rawlings R, Yolken RH. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res 1997;28:1-38.
24. Lewis G, David A, Andréasson S, Allebeck P. Schizophrenia and city life. Lancet 1992;340:137-140.
25. Takei N, Sham PC, O'Callaghan E, Glava G, Murray RM. Schizophrenia: increased risk association with winter and city birth-a casecontrol study in 12 regions within England and Wales. J Epid Community Health 1995;45:106-109.
26. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychoses as assessed in a US community sample: The National Comorbidity Survey, Arch Gen Psychiatry 1996;53:1022-1031.
27. Torrey EF, Bowler AE, Clark K. Urban birth and residence as risk factors for psychoses: an analysis of 1880 data. Schizophr Res 1997;25:169-176.
28. Verdoux H, Takei N, Casson de Saint-Mathurin R, Murray RM, Bourgeois ML. Seasonality of birth in schizophrenia: the effect of regional population density. Schizophr Res 1997;23:175-180.
29. Marcellus M, Navarro-Mateu F, Murray R, Selten J-P, Van Os J. Urbanization and psychosis: a study of 1942-1978 with cohorts in The Netherlands. Psych Med 1998;28:871-879.
30. Mortensen PB, Pederson CB, Westergaard T. Effects of family history and place and season of birth on the risk of schizophrenia. N Engl J Med 1999;340:603-608.
31. Torrey EF, Rawlings R, Yolken RH. The antecedents of psychoses: a case-control study of selected risk factors. Schizophr Res (2000) in press.
32. McNeil TF. Perinatal risk factors and schizophrenia: selective review and methodological concerns. Epid Rev 1995;17:107-112.
33. Dalman C, Allenbeck P, Culberg J, Grunewald C, Köster M. Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. Arch Gen Psych 1999;56:234-240.
34. Geddes JR, Verdoux H, Takei N. Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis. Schizophr Bull 1999;25:413-423.
35. Harrison G, Glazebrook C, Brewin J. Increased incidence of psychotic disorders in migrants from the Caribbean to the United Kingdom. Psych Med 1997;27:799-806.
36. Schweitzer LS, Su W-H. Population density and the rate of mental illness. Am J Public Health 1977;67:1165-1171.
37. Harvey CA, Pantelis C, Taylor J, McCabe PJ, Lefevre K, Campbell PG, Hirsch SR. The Camden Schizophrenia Surveys II. High prevalence of schizophrenia in an inner London borough and its relationship to socio-demographic factors. Br J Psychiatry 1996;168:418-426.
38. Westergaard T, Mortensen PB, Pedersen CB, Wohlfahrt J, Melbye M. Exposure to prenatal and childhood infections and the risk of schizophrenia: suggestions from a study of the sibship characteristics and influenza prevalence. Arch Gen Psych 1999;56:993998.
39. Torrey EF, Yolken RH. Could schizophrenia be a viral zoonosis transmitted from house cats? Schizophr Bull 1995;21:167-171.
40. Rantakallio P, Jones P, Moring J, von Wendt L. Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up. Int J Epid 1997;26:837-843.
41. Torrey EF, Rawlings E, Waldman IN. Schizophrenia births and viral diseases in two states. Schizophr Res 1988;1:73-77.
42. Bayer T, Falkai P, Maier W. Genetic and non-genetic vulnerability factors in schizophrenia. The basis of the 'Two hit hypothesis'. J Psych Res 1999;33:543-548.
43. Bayer TA, Buslei R, Havos L, Falkai P. Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci Lett 1999;271:126-128.
44. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-318.
45. Karlsson H, Bachmann S, Schröder J, McArthur J, Torrey EF, Yolken RH, Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia, (2000) submitted for publication.
46. Deb-Rinker R, Klempan TA, O'Reilly RL, Torrey EF, Singh SM. Molecular characteristics of a MSRV-like sequence identified by RDA from monozygotic twin pairs discordant for schizophrenia. Genomics 1999;61(2):133-144.
47. Kim HS, Wadekar RV, Takenaka O. SINE-R.C2 (a Homo sapiens specific retrospon) is homologous to cDNA from postmortem brain in schizophrenia and to two loci in the Xq21.3/Yp block linked to handedness and psychosis. Am J Med Genet 1999;88(5):560-566.
48. Hart DJ, Heath RG, Sautter Jr FL. Antiretroviral antibodies: implications for schizophrenia, schizophrenia spectrum disorders, and bipolar disorder. Biol Psychiatry 1999;45(6):704-714.
49. th Symposium on the Neurovirology and Neuroimmunology of Schizophrenia and Bipolar Disorder, Bethesda, MD, November 1999.
50. Schramm M, Falkai P, Bayer TH. Suppression subtractive hybridization: isolation of differentially expressed genes in schizophrenia. Med Genet 1999;3:450.
51. Martinand C, Salehzodo T, Silhol M, Lebleu B, Bisbal C. The RNase L exhibitor (RLI) is induced by double-stranded RNA. J Interferon Cytokine Res 1998;18:1031-1038.
52. th Symposium on the Neurovirology and Neuroimmunology of Schizophrenia and Bipolar Disorder, Bethesda, MD, November 1999.
53. Yolken RH, Karlsson H, Yee F, Johnston-Wilson NL, Torrey EF. Endogenous retrovirus and schizophrenia. Brain Res Rev 2000;3(2-3):193-199.